Sudeep Pharma Ltd.
•₹ 1,111.80.36%
2026-08-21
PROS
- Company has delivered good profit growth of 39.2% CAGR over last 5 years
- Company has a healthy return on capital (ROCE) of 37.7%
- Company has a good return on equity (ROE) track record: 3 Years ROE 34.7%
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 24.5% CAGR over last 5 years
- Operating margins have improved to 34.1% from 23.3%
CONS
- Promoter holding has decreased over last 2 years: -23.8pp
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.41x)
- Equity base is being diluted - shares outstanding up 701.6%
- Working capital days have increased from 174 to 235 days
- Stock is trading at 7.6x its book value
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SUDEEPPHRM | 1156.00 | 71.49 | 13056.86 | 0.13 | 405.87 | 1197.99 | 1582.70 | 1166.99 | 28.50 | 34.70 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| 149 | 116 | 158 | 125 | 163 | 172 | 182 | 158 | |
| 85 | 76 | 99 | 86 | 107 | 112 | 120 | 109 | |
| Operating Profit | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — |
| Other Income | 2 | 2 | 4 | 5 | 10 | 7 | 6 | 5 |
| Interest | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
| 62 | 38 | 58 | 44 | 60 | 62 | 63 | 54 | |
| Tax % | 21.01% | 23.77% | 23.63% | 29.05% | 21.43% | 22.79% | 22.59% | 25.24% |
| Net Profit | 0 | 0 | 0 | 31 | 47 | 48 | 49 | 41 |
| 4 | 3 | 4 | 0 | 4 | 4 | 4 | 0 | |
| Equity Capital | 4 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 4 | 10 | 10 | 10 | 10 | 11 | 11 | 11 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Sep 2024
- 149
- 85
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 3
- 62
- Tax %
- 21.01%
- Net Profit
- 0
- 4
- Equity Capital
- 4
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 4
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 116
- 76
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 3
- 38
- Tax %
- 23.77%
- Net Profit
- 0
- 3
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 158
- 99
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 2
- Depreciation
- 3
- 58
- Tax %
- 23.63%
- Net Profit
- 0
- 4
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 125
- 86
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 2
- Depreciation
- 3
- 44
- Tax %
- 29.05%
- Net Profit
- 31
- 0
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 163
- 107
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 2
- Depreciation
- 4
- 60
- Tax %
- 21.43%
- Net Profit
- 47
- 4
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 172
- 112
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 4
- 62
- Tax %
- 22.79%
- Net Profit
- 48
- 4
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 182
- 120
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 2
- Depreciation
- 4
- 63
- Tax %
- 22.59%
- Net Profit
- 49
- 4
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 158
- 109
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 2
- Depreciation
- 4
- 54
- Tax %
- 25.24%
- Net Profit
- 41
- 0
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 11
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 123 | 215 | 343 | 429 | 459 | 502 | 642 | 676 | |
| 98 | 171 | 276 | 339 | 277 | 311 | 419 | 449 | |
| Operating Profit | 29 | 48 | 75 | 100 | 189 | 200 | 251 | — |
| OPM % | 23 | 22 | 22 | 23 | 41 | 40 | 39 | — |
| Other Income | 3 | 3 | 7 | 10 | 6 | 9 | 29 | 29 |
| Interest | 1 | 1 | 2 | 6 | 5 | 7 | 9 | 8 |
| Depreciation | 3 | 4 | 5 | 8 | 9 | 11 | 15 | 16 |
| 25 | 43 | 69 | 86 | 175 | 183 | 228 | 238 | |
| Tax % | 27 | 23 | 27 | 28 | 24 | 24 | 24 | 23 |
| Net Profit | 18 | 33 | 50 | 62 | 133 | 139 | 174 | 184 |
| EPS | 128 | 237 | 356 | 6 | 945 | 14 | 15 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 10 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 3 | 5 | 6 | 14 | 14 | 15 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2 | 3 | 5 | 6 | 14 | 14 | 15 | — |
Mar 2020
- 123
- 98
- Operating Profit
- 29
- OPM %
- 23
- Other Income
- 3
- Interest
- 1
- Depreciation
- 3
- 25
- Tax %
- 27
- Net Profit
- 18
- EPS
- 128
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2021
- 215
- 171
- Operating Profit
- 48
- OPM %
- 22
- Other Income
- 3
- Interest
- 1
- Depreciation
- 4
- 43
- Tax %
- 23
- Net Profit
- 33
- EPS
- 237
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2022
- 343
- 276
- Operating Profit
- 75
- OPM %
- 22
- Other Income
- 7
- Interest
- 2
- Depreciation
- 5
- 69
- Tax %
- 27
- Net Profit
- 50
- EPS
- 356
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2023
- 429
- 339
- Operating Profit
- 100
- OPM %
- 23
- Other Income
- 10
- Interest
- 6
- Depreciation
- 8
- 86
- Tax %
- 28
- Net Profit
- 62
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2024
- 459
- 277
- Operating Profit
- 189
- OPM %
- 41
- Other Income
- 6
- Interest
- 5
- Depreciation
- 9
- 175
- Tax %
- 24
- Net Profit
- 133
- EPS
- 945
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 14
Mar 2025
- 502
- 311
- Operating Profit
- 200
- OPM %
- 40
- Other Income
- 9
- Interest
- 7
- Depreciation
- 11
- 183
- Tax %
- 24
- Net Profit
- 139
- EPS
- 14
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 14
Mar 2026
- 642
- 419
- Operating Profit
- 251
- OPM %
- 39
- Other Income
- 29
- Interest
- 9
- Depreciation
- 15
- 228
- Tax %
- 24
- Net Profit
- 174
- EPS
- 15
- Dividend Payout %
- 10
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 15
- Minority Interest
- -1
- Share of Associates
- 0
- Adjusted EPS
- 15
TTM
- 676
- 449
- Operating Profit
- —
- OPM %
- —
- Other Income
- 29
- Interest
- 8
- Depreciation
- 16
- 238
- Tax %
- 23
- Net Profit
- 184
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 24%
- 3 Years:
- 14%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 39%
- 3 Years:
- 41%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 34%
- 3 Years:
- 35%
- Last Year:
- 25%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| 1 | 1 | 1 | 1 | 1 | 10 | 11 | |
| 80 | 113 | 162 | 222 | 355 | 481 | 872 | |
| 12 | 17 | 55 | 62 | 54 | 86 | 102 | |
| Trade Payables | 9 | 18 | 27 | 38 | 51 | 60 | 68 |
| 29 | 64 | 98 | 96 | 53 | 80 | 121 | |
| Total Liabilities | 131 | 213 | 344 | 420 | 514 | 717 | 1,174 |
| ASSETS | - | - | - | - | - | - | - |
| 60 | 68 | 137 | 158 | 180 | 189 | 337 | |
| Capital Work in Progress | 8 | 24 | 8 | 26 | 45 | 88 | 178 |
| 6 | 19 | 0 | 3 | 0 | 0 | 0 | |
| 9 | 17 | 37 | 71 | 67 | 129 | 216 | |
| 0 | 0 | 0 | 0 | 145 | 185 | 228 | |
| Cash & Bank | 4 | 12 | 21 | 10 | 14 | 52 | 115 |
| 44 | 73 | 141 | 151 | 63 | 73 | 101 | |
| Total Assets | 131 | 213 | 344 | 420 | 514 | 717 | 1,174 |
| Total Debt | 20 | 31 | 84 | 82 | 75 | 135 | 148 |
| Net Working Capital | 20 | 20 | 50 | 59 | 138 | 249 | 422 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 574.46 | 810.48 | 1159.15 | 1584.71 | 2526.86 | 50.48 | 78.21 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 1.00 | 1.00 |
| Total Debt | 20 | 31 | 84 | 82 | 75 | 135 | 148 |
| Net Working Capital | 20 | 20 | 50 | 59 | 138 | 249 | 422 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 574.46 | 810.48 | 1159.15 | 1584.71 | 2526.86 | 50.48 | 78.21 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 1.00 | 1.00 |
Mar 2020
- 1
- 80
- 12
- Trade Payables
- 9
- 29
- Total Liabilities
- 131
- 60
- Capital Work in Progress
- 8
- 6
- 9
- 0
- Cash & Bank
- 4
- 44
- Total Assets
- 131
- Total Debt
- 20
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 574.46
- Face Value
- 10.00
- Total Debt
- 20
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 574.46
- Face Value
- 10.00
Mar 2021
- 1
- 113
- 17
- Trade Payables
- 18
- 64
- Total Liabilities
- 213
- 68
- Capital Work in Progress
- 24
- 19
- 17
- 0
- Cash & Bank
- 12
- 73
- Total Assets
- 213
- Total Debt
- 31
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 810.48
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- 20
- Contingent Liabilities
- 0
- Book Value per Share
- 810.48
- Face Value
- 10.00
Mar 2022
- 1
- 162
- 55
- Trade Payables
- 27
- 98
- Total Liabilities
- 344
- 137
- Capital Work in Progress
- 8
- 0
- 37
- 0
- Cash & Bank
- 21
- 141
- Total Assets
- 344
- Total Debt
- 84
- Net Working Capital
- 50
- Contingent Liabilities
- 0
- Book Value per Share
- 1159.15
- Face Value
- 10.00
- Total Debt
- 84
- Net Working Capital
- 50
- Contingent Liabilities
- 0
- Book Value per Share
- 1159.15
- Face Value
- 10.00
Mar 2023
- 1
- 222
- 62
- Trade Payables
- 38
- 96
- Total Liabilities
- 420
- 158
- Capital Work in Progress
- 26
- 3
- 71
- 0
- Cash & Bank
- 10
- 151
- Total Assets
- 420
- Total Debt
- 82
- Net Working Capital
- 59
- Contingent Liabilities
- 0
- Book Value per Share
- 1584.71
- Face Value
- 10.00
- Total Debt
- 82
- Net Working Capital
- 59
- Contingent Liabilities
- 0
- Book Value per Share
- 1584.71
- Face Value
- 10.00
Mar 2024
- 1
- 355
- 54
- Trade Payables
- 51
- 53
- Total Liabilities
- 514
- 180
- Capital Work in Progress
- 45
- 0
- 67
- 145
- Cash & Bank
- 14
- 63
- Total Assets
- 514
- Total Debt
- 75
- Net Working Capital
- 138
- Contingent Liabilities
- 0
- Book Value per Share
- 2526.86
- Face Value
- 10.00
- Total Debt
- 75
- Net Working Capital
- 138
- Contingent Liabilities
- 0
- Book Value per Share
- 2526.86
- Face Value
- 10.00
Mar 2025
- 10
- 481
- 86
- Trade Payables
- 60
- 80
- Total Liabilities
- 717
- 189
- Capital Work in Progress
- 88
- 0
- 129
- 185
- Cash & Bank
- 52
- 73
- Total Assets
- 717
- Total Debt
- 135
- Net Working Capital
- 249
- Contingent Liabilities
- 0
- Book Value per Share
- 50.48
- Face Value
- 1.00
- Total Debt
- 135
- Net Working Capital
- 249
- Contingent Liabilities
- 0
- Book Value per Share
- 50.48
- Face Value
- 1.00
Mar 2026
- 11
- 872
- 102
- Trade Payables
- 68
- 121
- Total Liabilities
- 1,174
- 337
- Capital Work in Progress
- 178
- 0
- 216
- 228
- Cash & Bank
- 115
- 101
- Total Assets
- 1,174
- Total Debt
- 148
- Net Working Capital
- 422
- Contingent Liabilities
- 0
- Book Value per Share
- 78.21
- Face Value
- 1.00
- Total Debt
- 148
- Net Working Capital
- 422
- Contingent Liabilities
- 0
- Book Value per Share
- 78.21
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 10 | 35 | -3 | 48 | 66 | 49 | 70 | |
| Cash from Investing | -22 | -40 | -38 | -50 | -49 | -79 | -331 |
| Cash from Financing | 12 | 13 | 51 | -10 | -13 | 53 | 247 |
| -0 | 8 | 10 | -11 | 4 | 23 | -14 | |
| Free Cash Flow | 10 | 8 | -61 | 21 | 16 | -14 | -183 |
| OCF / Net Profit | 0.55 | 1.06 | -0.06 | 0.78 | 0.49 | 0.35 | 0.40 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -29 | -220 |
| OCF / Net Profit | 0.55 | 1.06 | -0.06 | 0.78 | 0.49 | 0.35 | 0.40 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -29 | -220 |
Mar 2020
- 10
- Cash from Investing
- -22
- Cash from Financing
- 12
- -0
- Free Cash Flow
- 10
- OCF / Net Profit
- 0.55
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.55
- Cumulative 5-Year FCF
- 0
Mar 2021
- 35
- Cash from Investing
- -40
- Cash from Financing
- 13
- 8
- Free Cash Flow
- 8
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 0
Mar 2022
- -3
- Cash from Investing
- -38
- Cash from Financing
- 51
- 10
- Free Cash Flow
- -61
- OCF / Net Profit
- -0.06
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.06
- Cumulative 5-Year FCF
- 0
Mar 2023
- 48
- Cash from Investing
- -50
- Cash from Financing
- -10
- -11
- Free Cash Flow
- 21
- OCF / Net Profit
- 0.78
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.78
- Cumulative 5-Year FCF
- 0
Mar 2024
- 66
- Cash from Investing
- -49
- Cash from Financing
- -13
- 4
- Free Cash Flow
- 16
- OCF / Net Profit
- 0.49
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.49
- Cumulative 5-Year FCF
- 0
Mar 2025
- 49
- Cash from Investing
- -79
- Cash from Financing
- 53
- 23
- Free Cash Flow
- -14
- OCF / Net Profit
- 0.35
- Cumulative 5-Year FCF
- -29
- OCF / Net Profit
- 0.35
- Cumulative 5-Year FCF
- -29
Mar 2026
- 70
- Cash from Investing
- -331
- Cash from Financing
- 247
- -14
- Free Cash Flow
- -183
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- -220
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- -220
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 128.02 | 236.61 | 356.01 | 442.31 | 945.26 | 14.27 | 15.31 |
| Book Value (₹) | 574.46 | 810.48 | 1159.15 | 1584.71 | 2526.86 | 50.48 | 78.21 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.50 |
| Cash EPS (₹) | 2.17 | 3.80 | 5.63 | 7.23 | 14.65 | 15.36 | 16.74 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 23.25% | 22.09% | 21.82% | 23.25% | 39.73% | 36.47% | 34.05% |
| Net Margin % | 14.66% | 15.50% | 14.63% | 14.54% | 29.00% | 26.48% | 26.64% |
| ROE % | 22.28% | 34.17% | 36.15% | 32.24% | 45.98% | 32.76% | 25.37% |
| ROCE % | 25.25% | 35.71% | 35.85% | 33.22% | 48.76% | 35.83% | 28.50% |
| 13.79% | 19.41% | 18.03% | 16.33% | 28.54% | 22.55% | 18.43% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 90 | 73 | 86 | 85 | 95 | 115 | 115 |
| Inventory Days | 28 | 23 | 29 | 46 | 55 | 68 | 96 |
| Payable Days | 70 | 59 | 63 | 68 | 101 | 133 | 106 |
| 48 | 36 | 52 | 63 | 49 | 50 | 105 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.25x | 0.27x | 0.51x | 0.37x | 0.21x | 0.27x | 0.17x |
| Interest Coverage (x) | 27.51x | 45.43x | 40.89x | 15.87x | 37.92x | 27.49x | 27.82x |
| 1.54x | 1.25x | 1.34x | 1.35x | 2.01x | 2.43x | 3.09x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 74.86% | 59.46% | 24.99% | 7.12% | 9.30% | 27.94% |
| Operating Profit Growth % | 0.00% | 66.13% | 57.50% | 33.18% | 89.17% | 6.24% | 25.48% |
| Net Profit Growth % | 0.00% | 84.83% | 50.46% | 24.23% | 113.71% | 4.16% | 25.63% |
| 0.00% | 0.00% | 0.00% | 0.00% | 113.71% | -98.49% | 7.28% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 38.70x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 7.57x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.25% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.33x | 0.48x | 26.75x |
Mar 2020
- EPS (₹)
- 128.02
- Book Value (₹)
- 574.46
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.17
- Operating Margin %
- 23.25%
- Net Margin %
- 14.66%
- ROE %
- 22.28%
- ROCE %
- 25.25%
- 13.79%
- Debtor Days
- 90
- Inventory Days
- 28
- Payable Days
- 70
- 48
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 27.51x
- 1.54x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 236.61
- Book Value (₹)
- 810.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.80
- Operating Margin %
- 22.09%
- Net Margin %
- 15.50%
- ROE %
- 34.17%
- ROCE %
- 35.71%
- 19.41%
- Debtor Days
- 73
- Inventory Days
- 23
- Payable Days
- 59
- 36
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 45.43x
- 1.25x
- Revenue Growth %
- 74.86%
- Operating Profit Growth %
- 66.13%
- Net Profit Growth %
- 84.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 356.01
- Book Value (₹)
- 1159.15
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.63
- Operating Margin %
- 21.82%
- Net Margin %
- 14.63%
- ROE %
- 36.15%
- ROCE %
- 35.85%
- 18.03%
- Debtor Days
- 86
- Inventory Days
- 29
- Payable Days
- 63
- 52
- Debt to Equity (x)
- 0.51x
- Interest Coverage (x)
- 40.89x
- 1.34x
- Revenue Growth %
- 59.46%
- Operating Profit Growth %
- 57.50%
- Net Profit Growth %
- 50.46%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 442.31
- Book Value (₹)
- 1584.71
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.23
- Operating Margin %
- 23.25%
- Net Margin %
- 14.54%
- ROE %
- 32.24%
- ROCE %
- 33.22%
- 16.33%
- Debtor Days
- 85
- Inventory Days
- 46
- Payable Days
- 68
- 63
- Debt to Equity (x)
- 0.37x
- Interest Coverage (x)
- 15.87x
- 1.35x
- Revenue Growth %
- 24.99%
- Operating Profit Growth %
- 33.18%
- Net Profit Growth %
- 24.23%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 945.26
- Book Value (₹)
- 2526.86
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.65
- Operating Margin %
- 39.73%
- Net Margin %
- 29.00%
- ROE %
- 45.98%
- ROCE %
- 48.76%
- 28.54%
- Debtor Days
- 95
- Inventory Days
- 55
- Payable Days
- 101
- 49
- Debt to Equity (x)
- 0.21x
- Interest Coverage (x)
- 37.92x
- 2.01x
- Revenue Growth %
- 7.12%
- Operating Profit Growth %
- 89.17%
- Net Profit Growth %
- 113.71%
- 113.71%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.33x
Mar 2025
- EPS (₹)
- 14.27
- Book Value (₹)
- 50.48
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 15.36
- Operating Margin %
- 36.47%
- Net Margin %
- 26.48%
- ROE %
- 32.76%
- ROCE %
- 35.83%
- 22.55%
- Debtor Days
- 115
- Inventory Days
- 68
- Payable Days
- 133
- 50
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 27.49x
- 2.43x
- Revenue Growth %
- 9.30%
- Operating Profit Growth %
- 6.24%
- Net Profit Growth %
- 4.16%
- -98.49%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.48x
Mar 2026
- EPS (₹)
- 15.31
- Book Value (₹)
- 78.21
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 16.74
- Operating Margin %
- 34.05%
- Net Margin %
- 26.64%
- ROE %
- 25.37%
- ROCE %
- 28.50%
- 18.43%
- Debtor Days
- 115
- Inventory Days
- 96
- Payable Days
- 106
- 105
- Debt to Equity (x)
- 0.17x
- Interest Coverage (x)
- 27.82x
- 3.09x
- Revenue Growth %
- 27.94%
- Operating Profit Growth %
- 25.48%
- Net Profit Growth %
- 25.63%
- 7.28%
- P/E (x)
- 38.70x
- P/B (x)
- 7.57x
- Dividend Yield %
- 0.25%
- 26.75x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-11 - Sudeep Pharma Limited has informed the Exchange about Transcript
- Updates
2026-08-06 - Sudeep Pharma Limited has informed the Exchange regarding 'General Update'.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026